Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aeris Partners is a boutique technology M&A investment bank and registered broker-dealer that advises software and SaaS companies, private equity firms, and founders on mergers and acquisitions, recapitalizations, and private placements. The firm is not a drug developer, biotech, pharma, or healthcare operator; however, it is active in healthcare IT and pharma IT advisory, with transactions involving laboratory information systems, population health, behavioral health software, life sciences procurement software, and other healthcare technology assets. Aeris has offices in Boston and San Francisco and states that its senior leadership team has completed more than $40 billion of software and SaaS M&A transactions. Its healthcare-relevant work includes advisory roles on transactions involving Orchard Software, Azara Healthcare, Qualifacts, WebPT, ESO, and Prendio-BioProcure. For a biotech analyst, Aeris is best understood as a specialist advisor to health-tech and pharma-tech software businesses rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aeris Partners.